Analysis of the concentration-respiratory response among asthmatics following controlled short-term exposures to sulfur dioxide

Inhalation Toxicology

Volumn 22, Issue 14, 2010, Pages 1184-1193

  Johns, Douglas O ^a   Svendsgaard, David ^a   Linn, William S ^b,c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b Los Amigos Research and Education Institute   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

asthma; bronchoconstriction; concentration response; controlled human exposures; National Ambient Air Quality Standards; Sulfur dioxide

Indexed keywords

SULFUR DIOXIDE;

ADULT; AMBIENT AIR; ARTICLE; ASTHMA; BRONCHOSPASM; CHEMICAL ANALYSIS; CHEST TIGHTNESS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERVENTILATION; LUNG FUNCTION; MORBIDITY; PARTICULATE MATTER; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SCORING SYSTEM; WHEEZING;

ADULT; ASTHMA; DOSE-RESPONSE RELATIONSHIP, DRUG; FORCED EXPIRATORY VOLUME; HUMANS; INHALATION EXPOSURE; MALE; PARTICULATE MATTER; RESPIRATORY FUNCTION TESTS; SULFUR DIOXIDE; TIME FACTORS; YOUNG ADULT;

EID: 78649934242     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2010.535220     Document Type: Article

References (32)

1. Arts JH, de Heer C, Woutersen RA. (2006). Local effects in the respiratory tract: relevance of subjectively measured irritation for setting occupational exposure limits. Int. Arch. Occup. Environ. Health, 79, 283-298.
2. ATS (American Thoracic Society). (2000). What constitutes an adverse health effect of air pollution? Am. J. Respir. Crit. Care Med., 161:665-673.
3. Balmes JR, Fine JM, Sheppard D. 1987. Symptomatic bronchoconstriction after short-term inhalation of sulfur dioxide. Am. Rev. Respir. Dis., 136:1117-1121. (Pubitemid 17151072)
4. Banzett RB, Dempsey JA, O'Donnell DE, Wamboldt MZ. 2000. Symptom perception and respiratory sensation in asthma. Am. J. Respir. Crit. Care Med., 162:1178-1182.
5. Bethel RA, Sheppard D, Geffroy B, Tam E, Nadel JA, Boushey HA. 1985. Effect of 0.25 ppm sulfur dioxide on airway resistance in freely breathing, heavily exercising, asthmatic subjects. Am. Rev. Respir. Dis., 131:659-661.
6. Coleridge HM and Coleridge JCG. (1986). Reflexes evoked from tracheobronchial tree and lungs. In: Cherniack NS and Widdicombe JG, Eds. Handbook of Physiology (Vol 2). Washington, DC: American Physiological Society: 395-429.
7. Fritz GK, Adams SK, McQuaid EL, Klein R, Kopel S, Nassau J, Mansell A. 2007. Symptom perception in pediatric asthma: resistive loading and in vivo assessment compared. Chest, 132:884-889.
8. Gong H, Lachenbruch PA, Harber P, Linn WS. 1995. Comparative short-term health responses to sulfur dioxide exposure and other common stresses in a panel of asthmatics. Toxicol. Ind. Health, 11:467-487.
9. Gong H Jr, Linn WS, Shamoo DA, Anderson KR, Nugent CA, Clark MS, Lin AE. 1996. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects. Chest, 110:1229-1235.
10. Gong H Jr, Linn WS, Terrell SL, Anderson KR, Clark MS. 2001. Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide. Chest, 119:402-408.
11. Hackney JD, Linn WS, Bailey RM, Spier CE, Valencia LM. 1984. Time course of exercise-induced bronchoconstriction in asthmatics exposed to sulfur dioxide. Environ. Res., 34, 321-327.
12. Henderson R. (2008). Letter to EPA Administrator Stephen Johnson: Clean Air Scientifc Advisory Committee's (CASAC) Peer Review of EPA's Integrated Science Assessment (ISA) for Sulfur Oxides-Health Criteria (Second External Review Draft, May 2008). August 8, 2008.
13. Horstman DH, Seal E Jr, Folinsbee LJ, Ives P, Roger LJ. 1988. The relationship between exposure duration and sulfur dioxide-induced bronchoconstriction in asthmatic subjects. Am. Ind. Hyg. Assoc. J., 49:38-47.
14. Jaeger MJ, Tribble D, Wittig HJ. 1979. Effect of 0.5 ppm sulfur dioxide on the respiratory function of normal and asthmatic subjects. Lung, 156:119-127. (Pubitemid 9250079)
15. Johns D. (2009). Presentation and analysis of controlled human exposure data described in Table 3-1 of the 2008 Integrated Science Assessment (ISA) for Sulfur Oxides. Memorandum to Docket No. EPA-HQ-ORD-2006-0260, Document No. 0032.
16. Johns D and Simmons K. (2009). Quality assurance review of individual subject data presented in Table 3-1 of the 2008 Integrated Science Assessment (ISA) for Sulfur Oxides. Memorandum to Docket No. EPA-HQ-ORD-2006-0260, Document No. 0036.
17. Johns DO and Linn WS. A Review of Controlled Human SO2 Exposure Studies Contributing to the U. S. EPA Integrated Science Assessment for Sulfur Oxides. Inhal. Toxicol. (in press).
18. Koenig JQ, Marshall SG, Horike M, Shapiro GG, Furukawa CT, Bierman CW, Pierson WE. 1987. The effects of albuterol on sulfur dioxide-induced bronchoconstriction in allergic adolescents. J. Allergy Clin. Immunol., 79:54-58.
19. Koenig JQ, Marshall SG, van Belle G, McManus MS, Bierman CW, Shapiro GG, Furukawa CT, Pierson WE. 1988. Therapeutic range cromolyn doseresponse inhibition and complete obliteration of SO2-induced bronchoconstriction in atopic adolescents. J. Allergy Clin. Immunol., 81:897-901.
20. Koenig JQ, Dumler K, Rebolledo V, Williams P V, Pierson WE. 1992. Theophylline mitigates the bronchoconstrictor effects of sulfur dioxide in subjects with asthma. J. Allergy Clin. Immunol., 89:789-794.
21. Linn WS, Venet TG, Shamoo DA, Valencia LM, Anzar UT, Spier CE, Hackney JD. 1983. Respiratory effects of sulfur dioxide in heavily exercising asthmatics. A dose-response study. Am. Rev. Respir. Dis., 127:278-283.
22. Linn WS, Avol EL, Shamoo DA, Venet TG, Anderson KR, Whynot JD, Hackney JD. 1984. Asthmatics' responses to 6-hr sulfur dioxide exposures on two successive days. Arch. Environ. Health, 39:313-319.
23. Linn WS, Avol EL, Peng RC, Shamoo DA, Hackney JD. 1987. Replicated doseresponse study of sulfur dioxide effects in normal, atopic, and asthmatic volunteers. Am. Rev. Respir. Dis., 136:1127-1134.
24. Linn WS, Avol EL, Shamoo DA, Peng RC, Spier CE, Smith MN, Hackney JD. 1988. Effect of metaproterenol sulfate on mild asthmatics' response to sulfur dioxide exposure and exercise. Arch. Environ. Health, 43:399-406.
25. Linn WS, Shamoo DA, Peng RC, Clark KW, Avol EL, Hackney JD. 1990. Responses to sulfur dioxide and exercise by medication-dependent asthmatics: effect of varying medication levels. Arch. Environ. Health, 45:24-30.
26. Nowak D, Jörres R, Berger J, Claussen M, Magnussen H. 1997. Airway responsiveness to sulfur dioxide in an adult population sample. Am. J. Respir. Crit. Care Med., 156:1151-1156.
27. Roger LJ, Kehrl HR, Hazucha M, Horstman DH. 1985. Bronchoconstriction in asthmatics exposed to sulfur dioxide during repeated exercise. J. Appl. Physiol., 59:784-791.
28. Schachter EN, Witek TJ Jr, Beck GJ, Hosein HB, Colice G, Leaderer BP, Cain W. 1984. Airway effects of low concentrations of sulfur dioxide: dose-response characteristics. Arch. Environ. Health, 39:34-42.
29. Sheppard D, Wong WS, Uehara CF, Nadel JA, Boushey HA. 1980. Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide. Am. Rev. Respir. Dis., 122:873-878.
30. Sheppard D, Epstein J, Bethel RA, Nadel JA, Boushey HA. 1983. Tolerance to sulfur dioxide-induced bronchoconstriction in subjects with asthma. Environ. Res., 30:412-419. (Pubitemid 13105270)
31. U. S. EPA. (2008). Integrated science assessment for sulfur oxides - health criteria. EPA/600/R-08/047F, National Center for Environmental Assessment, Office of Research and Development, U. S. Environmental Protection Agency, Research Triangle Park, NC.
32. Winterton DL, Kaufman J, Keener C V, Quigley S, Farin FM, Williams P V, Koenig JQ. 2001. Genetic polymorphisms as biomarkers of sensitivity to inhaled sulfur dioxide in subjects with asthma. Ann. Allergy Asthma Immunol., 86:232-238.